Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) generates a steady flow of news related to digital investigations, AI-powered analytics and public safety technology. As a global provider of digital investigative and intelligence solutions for public safety organizations, intelligence agencies, defense organizations and enterprises, the company frequently issues updates on its software platform, strategic initiatives and regulatory milestones.
News about Cellebrite often covers product and platform innovation, including releases that expand its Digital Investigation Platform. Recent announcements have highlighted enhancements to its flagship digital forensics solution, Inseyets, the expanded and reimagined Guardian suite for investigations and analytics, and the introduction of Guardian Investigate, a SaaS-based investigative solution that uses agentic AI to analyze multiple evidence types. Updates also describe new deployment options such as AWS GovCloud for Pathfinder and developments in the Cellebrite Government Cloud.
Investors and practitioners following CLBT news will also see corporate and strategic developments, such as the agreement and subsequent completion of the Corellium acquisition, which adds Arm-based mobile virtualization capabilities for security research and testing. Other coverage includes leadership changes, like the appointment of a new chief executive officer and chief financial officer, and governance events such as shareholder meeting outcomes.
Cellebrite’s news flow additionally features public sector and compliance milestones, including progress toward FedRAMP High authorization for its government cloud environment with sponsorship from the U.S. Department of Justice, and partnerships that support investigations into crimes against children. For ongoing insight into how Cellebrite’s technology, customer relationships and regulatory posture evolve, readers can review this CLBT news page regularly for the latest press releases and official updates.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.